US Patent Litigations are now available. Check here

Explore patent oppositions filed by Medicines against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3071206Gastrin Antagonists (Eg Yf476, Netazepide) For Treatment And Prevention Of OsteoporosisCL BIOSCIENCESNov 17, 2021
EP1857547Further Novel Forms Of Interfering Rna MoleculesATUGENOct 16, 2018
EP2258847Futher Novel Forms Of Interfering Rna MoleculesSILENCE THERAPEUTICSDec 14, 2017

Explore Medicines's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2731562Aug 10, 2022Intrautinary Systems, Iud Insertion Devices, And Related Methods And Kits Therefor2